Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

DSLD label record: NMN powder by BulkSupplements.com

This DSLD record lists a BulkSupplements.com powder labelled with 250 mg beta-nicotinamide mononucleotide per labelled serving. It is a label declaration only and does not show efficacy, safety or approval. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
NMN (Nicotinamide Mononucleotide)Original label · NIH DSLD
NMN (Nicotinamide Mononucleotide)

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
50 Gram(s) · 1.76 Ounce(s)
Label serving
250 mg
Servings per container
200
Barcode / SKU
X002NDJB7V
Open original label (PDF)
Ingredients & declared amounts1

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Beta-Nicotinamide Mononucleotide250 mg250 mg

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. DSLD record 311129 lists a BulkSupplements.com powder labelled NMN (Nicotinamide Mononucleotide). [1]

  2. The label declares 250 mg beta-nicotinamide mononucleotide per labelled serving. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. [1]

The source at a glance

Brand
BulkSupplements.com
Form
Powder
Pack contents
50 Gram(s) · 1.76 Ounce(s)
Label serving
250 mg
Ingredients listed
Beta-Nicotinamide Mononucleotide
Record type / format
Dietary supplement label/database record
Scope / context
The described product: BulkSupplements.com NMN powder, DSLD record 311129
Summary based on
Product label / database record

NMN powder record in the NIH DSLD

The NIH Office of Dietary Supplements lists this entry in its Dietary Supplement Label Database as record 311129. The label name is NMN (Nicotinamide Mononucleotide), the declared brand is BulkSupplements.com and the physical form is powder. The database category is Non-Nutrient/Non-Botanical. The label entered the database on 2024-04-23; the record notes this is not a product launch date.

Supporting source [1]

Declared ingredient: 250 mg NMN per serving

The only declared ingredient in this record is beta-nicotinamide mononucleotide, listed at 250 mg per labelled serving. This amount is a label fact, not personal dosing advice. The record supplies no independent product testing, price or batch certificate.

Supporting source [1]

What this label record does not establish

Inclusion in the DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The record describes label declarations only and is not a study, an independent lab test or an endorsement.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. The record describes label declarations only; no independent testing, price or batch certificate is supplied, and current retail availability is not established.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
NMN (Nicotinamide Mononucleotide)

BulkSupplements.com · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Product label name: NMN (Nicotinamide Mononucleotide)
  2. Finding 2 ↑

    Beta-Nicotinamide Mononucleotide: 250 mg per labelled serving
  3. Finding 3 ↑

    DSLD inclusion does not establish efficacy, safety,

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…